News & Events
News, industry insights and noteworthy events.
At Tanner, we take pride in the success of our partnerships and acknowledge the milestones achieved in pursuing our mission; to improve lives by increasing access to medicines around the world.
For media or press inquiries, please email us.
Contact UsAll Articles
-
Tanner Pharma Group Initiates Named Patient Program for XIAFLEX®
CHARLOTTE, NC –Tanner Pharma Group, Inc. today announced they have partnered with Endo Pharmaceuticals, Inc. to initiate a multi-year Named Patient Program for XIAFLEX® (collagenase clostridium histolyticum), an important nonsurgical treatment option for patients with Dupuytren’s contracture and Peyronie’s disease. XIAPEX®, also owned by Endo, was previously marketed by Swedish Orphan Biovitrum AB (Sobi) in…
Read More